US20170112865A1

Treatment for melanoma

University of Texas Southwestern

Abstract

The present invention relates to combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such combination in include MEK inhibitors, BRAF inhibitors and cardiac glycosides.

University: University of Texas Southwestern
Assignee: The Board Of Regents Of The University Of Texas System
Inventor: Sean J. Morrison
Priority date: May 21, 2014
Filing date: April 28, 2015
Publication date: April 27, 2017
Language: en
PDF source: https://patentimages.storage.googleapis.com/59/2b/1f/f569768b1a73db/US20170112865A1.pdf
Metadata fetched: August 28, 2026 19:17